• contact@literaturepublishers.org
  • Whitley Bay, NE26 2HU, England, United Kingdom
  • Open Access
Article Details
Case Report
Volume 5, Issue 2 (February Issue)

Neurologic Involvement in COVID-19: A Diagnostic Challenge

Ana Correia de Sá*, Marta Baptista, Nuno Carvalho, Daniela Casanova, Ana Luís Ferreira, Juliana Silva and Jorge Cotter

Internal Medicine, Hospital Senhora da Oliveira, Guimarães, Portugal

*Corresponding author: Ana Correia de Sá, Internal Medicine, Hospital Senhora da Oliveira, Guimarães, Portugal. E-mail: ana_isabelsa@hotmail.com

Received: January 16, 2023; Accepted: January 25, 2023; Published: February 15, 2023

Citation: Correia de Sá A, Baptista M, Carvalho N, et al. Neurologic Involvement in COVID-19: A Diagnostic Challenge. Clin Image Case Rep J. 2023; 5(2): 298.

Article Image

The 2019 Coronavirus Disease (COVID-19) is a pandemic disease caused by severe acute respiratory syndrome coronavirus 2. Respiratory symptoms are the most common, however neurologic symptoms have been reported in more than a third of patients with this infection. The virus can take different pathways to involve the central nervous system, but the exact pathologic basis for this neurologic involvement is currently unknown. This paper describes the case of a 26-year-old female with COVID-19 who presented to the emergency department with spatial and temporal disorientation and slurred speech. The diagnosis of encephalitis was made and a status epilepticus was documented. Several etiologies had been investigated and the only finding was COVID-19. Brain magnetic resonance reveled periventricular white matter lesions compatible with demyelinating lesions, similar to other cases published with literature concerning COVID-19 patients.

Keywords: Encephalitis; Status epilepticus; SARS-CoV-2; Periventricular white matter lesion